Bank of America’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.04M Buy
1,110,480
+628,570
+130% +$2.29M ﹤0.01% 3493
2025
Q1
$925K Sell
481,910
-62,006
-11% -$119K ﹤0.01% 4400
2024
Q4
$1.03M Buy
543,916
+294,343
+118% +$559K ﹤0.01% 4216
2024
Q3
$329K Buy
249,573
+22,429
+10% +$29.6K ﹤0.01% 4899
2024
Q2
$232K Sell
227,144
-128,312
-36% -$131K ﹤0.01% 5014
2024
Q1
$650K Buy
355,456
+132,637
+60% +$243K ﹤0.01% 4401
2023
Q4
$276K Sell
222,819
-1,259
-0.6% -$1.56K ﹤0.01% 4992
2023
Q3
$255K Buy
224,078
+121,550
+119% +$139K ﹤0.01% 4897
2023
Q2
$93.8K Sell
102,528
-90,931
-47% -$83.2K ﹤0.01% 5381
2023
Q1
$108K Buy
193,459
+59,695
+45% +$33.4K ﹤0.01% 5435
2022
Q4
$77.2K Sell
133,764
-147,942
-53% -$85.4K ﹤0.01% 5569
2022
Q3
$90K Sell
281,706
-183,382
-39% -$58.6K ﹤0.01% 5571
2022
Q2
$164K Buy
465,088
+60,835
+15% +$21.5K ﹤0.01% 5461
2022
Q1
$290K Sell
404,253
-54,826
-12% -$39.3K ﹤0.01% 5475
2021
Q4
$1.04M Buy
459,079
+300,669
+190% +$679K ﹤0.01% 4493
2021
Q3
$456K Buy
158,410
+71,863
+83% +$207K ﹤0.01% 4929
2021
Q2
$328K Sell
86,547
-178,660
-67% -$677K ﹤0.01% 4996
2021
Q1
$898K Buy
265,207
+191,125
+258% +$647K ﹤0.01% 4341
2020
Q4
$208K Sell
74,082
-35,574
-32% -$99.9K ﹤0.01% 4864
2020
Q3
$275K Sell
109,656
-37,771
-26% -$94.7K ﹤0.01% 4509
2020
Q2
$2M Sell
147,427
-57,917
-28% -$786K ﹤0.01% 3232
2020
Q1
$1.56M Buy
205,344
+52,900
+35% +$401K ﹤0.01% 3249
2019
Q4
$964K Sell
152,444
-32,819
-18% -$208K ﹤0.01% 3877
2019
Q3
$727K Sell
185,263
-183,116
-50% -$719K ﹤0.01% 4101
2019
Q2
$1.78M Buy
368,379
+85,513
+30% +$414K ﹤0.01% 3531
2019
Q1
$2.32M Buy
282,866
+142,752
+102% +$1.17M ﹤0.01% 3331
2018
Q4
$775K Sell
140,114
-2,823
-2% -$15.6K ﹤0.01% 3977
2018
Q3
$1.26M Sell
142,937
-173,612
-55% -$1.53M ﹤0.01% 3726
2018
Q2
$3.16M Buy
316,549
+55,790
+21% +$557K ﹤0.01% 3101
2018
Q1
$2.49M Buy
260,759
+68,167
+35% +$650K ﹤0.01% 3219
2017
Q4
$2.86M Sell
192,592
-116,938
-38% -$1.74M ﹤0.01% 3107
2017
Q3
$6.09M Buy
309,530
+15,672
+5% +$308K ﹤0.01% 2589
2017
Q2
$4.22M Sell
293,858
-107,300
-27% -$1.54M ﹤0.01% 2758
2017
Q1
$3.69M Sell
401,158
-86,391
-18% -$795K ﹤0.01% 2842
2016
Q4
$5.08M Sell
487,549
-18,225
-4% -$190K ﹤0.01% 2482
2016
Q3
$4.58M Sell
505,774
-38,889
-7% -$352K ﹤0.01% 2474
2016
Q2
$4.07M Sell
544,663
-546,218
-50% -$4.09M ﹤0.01% 2496
2016
Q1
$9.83M Buy
1,090,881
+413,880
+61% +$3.73M ﹤0.01% 1826
2015
Q4
$8.75M Buy
677,001
+348,330
+106% +$4.5M ﹤0.01% 1955
2015
Q3
$3.18M Buy
328,671
+227,318
+224% +$2.2M ﹤0.01% 2713
2015
Q2
$1.04M Buy
101,353
+82,334
+433% +$847K ﹤0.01% 3264
2015
Q1
$211K Sell
19,019
-4,010
-17% -$44.5K ﹤0.01% 3985
2014
Q4
$268K Buy
23,029
+21,448
+1,357% +$250K ﹤0.01% 3980
2014
Q3
$35K Buy
+1,581
New +$35K ﹤0.01% 5032